 as a mimic for the ketogenic diet, and shows great promise as a new anti-epileptic drug.The authors suggest that 2-DG works, in part, by increasing the expression of Brain-derived neurotrophic factor (BDNF), Nerve growth factor (NGF), Arc (protein) (ARC), and Basic fibroblast growth factor (FGF2).Such uses are complicated by the fact that 2-deoxyglucose does have some toxicity.